<DOC>
	<DOC>NCT00259896</DOC>
	<brief_summary>This study is a placebo-controlled study in both healthy normal subjects and patients with Type 2 Diabetes Mellitus to assess the levels of exenatide in the bloodstream when it is given for 7 days, and to assess the impact this medication has on various substances in the blood. Assessments include repeat blood sampling and monitoring of any side effects.</brief_summary>
	<brief_title>In-patient Study in Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<criteria>have type 2 diabetes mellitus that has been diagnosed for at least three months must be taking either (1) no medication for their diabetes or (2) taking metformin, a sulfonylurea, or metformin and a sulfonylurea must be willing to washout of these medications for 14 days prior to the start of the study must have bloodwork that meets certain criteria (for example, total cholesterol &lt; 240 mg/dL) must not have any other major illness other than diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>66 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>exenatide</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>pharmacodynamics</keyword>
</DOC>